Regulations.gov document: Reference 4 Safety of Lumason R SonoVue R in special populations and critically ill patients

retained text

Query: data center
Agency: FDA
Type: Supporting & Related Material
Docket: FDA-2026-P-11816

document fetched 2026-10-09 02:41 · canonical https://regulations.gov/document/FDA-2026-P-11816-0006